Medgenics has three long-acting protein therapy products in development based on this technology:

EPODURE (now completing a Phase I/II dose-ranging trial) to produce and deliver erythropoietin for many months from a single administration, has demonstrated elevation and stabilization of hemoglobin levels in anemic patients for six to more than 36 months;

To view video click URL link here: http://crweselect.com/25155/stock-alerts/mck-ixys-ivac-crweselectcom-sto...

McKesson Corporation (NYSE:MCK)

Orofino Gold Corp. (ORFG.PK) is a China based gold producer with one producing gold mine in Colombia and an option on a strong portfolio of small producers and development/exploration assets in Colombia.